April 2 (Reuters) - EMvision Medical Devices Ltd EMV.AX :
* AFTER TWO MONTHS OF SIX-MONTH TRIAL, SUCCESSFULLY ENROLLED HALF OF TARGET PATIENT COHORT
* TEMPORARILY PAUSING ADDITIONAL PATIENT ENROLMENT IN TRIAL DUE TO DEMAND ON HOSPITAL STAFFING FROM COVID-19
* EXPECTS TO REPORT PRELIMINARY IMAGES FROM ITS CLINICAL TRIAL THIS MONTH
* HAD $6.87M CASH AS AT 31 DEC 2019 AND REMAINS WELL FUNDED TO COMPLETE CLINICAL TRIAL